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Strategies to Improve Regeneration
of the Soft Palate Muscles After Cleft Palate Repair
Paola L. Carvajal Monroy, D.D.S., M.Sc., Sander Grefte, Ph.D.,*
Anne Marie Kuijpers-Jagtman, D.D.S., Ph.D., Frank A.D.T.G. Wagener, Ph.D.,
and Johannes W. Von den Hoff, Ph.D.
Children with a cleft in the soft palate have difficulties with speech, swallowing, and sucking. These patients are
unable to separate the nasal from the oral cavity leading to air loss during speech. Although surgical repair
ameliorates soft palate function by joining the clefted muscles of the soft palate, optimal function is often not
achieved. The regeneration of muscles in the soft palate after surgery is hampered because of (1) their low
intrinsic regenerative capacity, (2) the muscle properties related to clefting, and (3) the development of fibrosis.
Adjuvant strategies based on tissue engineering may improve the outcome after surgery by approaching these
specific issues. Therefore, this review will discuss myogenesis in the noncleft and cleft palate, the characteristics
of soft palate muscles, and the process of muscle regeneration. Finally, novel therapeutic strategies based on
tissue engineering to improve soft palate function after surgical repair are presented.
Introduction
Cleft lip and/or palate (CLP) is the most commoncongenital facial malformation in humans. It occurs in
about 1/500 to 1/1000 births, with ethnic and geographic
variation.1 This disorder is generally divided into two
groups: clefts involving the lip with or without cleft palate
and isolated cleft palate2 (Fig. 1). CLP can also be part of a
syndrome when it is associated with other congenital de-
fects.3 In this review we will focus on clefts involving the soft
palate.
Children with a cleft in the soft palate have difficulties
with speech, swallowing, and sucking. These patients are
unable to separate the nasal from the oral cavity; a phe-
nomenon known as velopharyngeal dysfunction. Surgical
repair is required to close the defect and to reconstruct the
muscle sling of the m. levator veli palatini (LVP), the major
muscle of the soft palate4 (Fig. 2). It ensures optimal function
and normal speech development.5,6 However, about 10% to
30% of the treated patients remain unable to achieve ade-
quate velopharyngeal function.7,8 This results in hypernasal
speech that often requires additional surgical corrections.
Diverse factors are attributed to suboptimal repair such as
age at the time of the surgery, skills and experience of the
surgeon, type and extension of the cleft, fibrosis, damage of
the motor and proprioceptive innervation, and abnormal fi-
ber type distribution.7,9–12
This review will highlight the myogenesis and character-
istics of the soft palate muscles in the noncleft and cleft
palate, and the process of muscle regeneration. We postulate
that muscle healing and function after soft palate repair can
be improved by adjuvant strategies from the field of regen-
erative medicine. How these novel adjuvant strategies based
on tissue engineering could improve muscle healing and
prevent velopharyngeal dysfunction after surgical repair will
be discussed.
Soft Palate Myogenesis
The muscles of the soft palate and those controlling jaw
movement, facial expression, and pharyngeal (throat) and
laryngeal (voice box) function are known as branchiomeric
muscles.13,14 The formation of the soft palate muscles starts
already early in embryonic development and yields five
pairs of muscles: (1) the tensor veli palatini (TVP), (2) the
LVP, (3) the palatopharyngeus (PP), (4) the palatoglossus
(PG), and 5) the uvulae (U) (Fig. 2). Mesenchymal conden-
sations of the individual soft palate muscles emerge se-
quentially, starting from the sixth week of gestation in
humans, with the TVP appearing first and the U last. Their
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full morphological development is completed after the 17th
week of intrauterine life. The hard palate is already fused at
this stage. The masticatory muscles and the TVP develop at
the same time, and are followed by the morphogenesis of the
LVP, PP, PG, and U muscles, and by the palatal aponeurosis
(PA).15,16 The development of the soft palate muscles in cleft
patients is delayed compared with noncleft individuals.17
Soft Palate Muscles in the Normal and Cleft Palate
The soft palate is formed by an interweaving of muscles
from the skull base (TVP and LVP), tongue (PG), and phar-
ynx (PP; Fig. 2). All muscles extend from nearby bony
structures and are inserted into the PA located in the center
of the soft palate (Fig. 2). Hence, all muscles have only one
skeletal insertion, with the exception of the U, which is a
completely intrinsic muscle of the soft palate without bony
attachment. In the cleft palate, the muscles are attached to the
posterior border of the hard palate (Fig. 2). The abnormal
insertions of the muscles, in particular the LVP, in cleft palate
patients prevent normal functioning. These muscles have
two instead of one skeletal attachments limiting them to
isometric contractions.18 As a result, the cleft muscles pull the
two halves of the soft palate in a superior and lateral direc-
tion, causing further widening of the cleft.19 In addition, the
LVP may become severely atrophic because of reduced
function, and often has only half of the thickness found in
healthy newborns. The LVP myofibers are also disorganized
next to the cleft margin.16,17
Both slow and fast fibers are present in the soft palate
muscles. Slow fibers are highly resistant to fatigue, with a low
activation threshold, whereas fast fibers are more fatiguable,
with a higher activation threshold. In noncleft individuals, the
LVP contains predominantly slow fibers,20,21 whereas in cleft
individuals it contains a higher proportion of fast fibers and a
reduced capillary supply compared with normal LVP mus-
cles.22–24 A fetal myosin heavy chain isoform is also present in
a small number of fibers in all palatal muscles. In comparison
with limb muscles, the individual and intramuscular vari-
ability in fiber diameter of the LVP is much larger.21 The
higher number of fast fibers in cleft patients may cause the
increased fatigability of the LVP during speech,23 which
FIG. 2. Muscles of the soft palate. m. tensor veli palatini
(TVP), m. levator veli palatini (LVP), the major muscle of the
soft palate (black), m. palatopharyngeus (PP), m. pala-
toglossus (PG), m. uvulae (U), and palatal aponeurosis (PA).
The dashed line indicates the posterior border of the hard
palate. Notice the abnormal insertion of the soft palate
muscles into the posterior border of the hard palate at the
cleft side. In this area disorganized myofibers are present.
Cleft palate muscles are limited to isometric contractions and
often underdeveloped.
FIG. 1. Cleft lip and/or palate. (a) Cleft lip. (b) Unilateral cleft lip and palate. (c) Bilateral cleft lip and palate. (d) Isolated
cleft palate. The dashed line indicates the posterior border of the hard palate.
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contributes to velopharyngeal dysfunction.25 Further, fast fi-
bers are more prone to contraction-induced injury.24,26,27
Muscle Regeneration in the Soft Palate
In general, muscles possess a strong ability to regenerate
after injury. Satellite cells (SatCs)28 are the primary muscle
stem cells, and are responsible for postnatal muscle growth,
maintenance, and repair. After injury, adjacent SatCs become
activated and migrate to the site of injury, proliferate, differ-
entiate, and fuse to form new myofibers or repair damaged
ones.29,30 In addition, signaling molecules from infiltrating
macrophages, injured myofibers, and the disrupted extracel-
lular matrix participate in the regeneration process.29–31 The
formation of scar tissue may prevent proper muscle regener-
ation.32–34The majority of studies on muscle regeneration
have been performed in limb muscles, while studies on head
muscles are scarce. Muscles from the limbs and the head differ
in several aspects. Skeletal muscles from the trunk and limbs
are derived from the somites35 during embryonic develop-
ment, while most head muscles including those of the soft
palate are derived from the branchial arches.36–38 The mas-
seter muscle, a branchiomeric muscle, seems to contain less
SatCs than limb muscle.39 Freeze or crush injuries in the
masseter muscle also regenerate much slower than similar
injuries in limb muscles.40 Moreover, much more fibrous
connective tissue is formed in the damaged area. Proliferating
SatCs from limb and head muscle also express a distinct
profile of transcription factors.39 In vitro, SatC-derived myo-
blasts from masseter proliferate more but differentiate later
than those from limb muscle. Remarkably, both SatC popu-
lations are similarly able to regenerate limb muscle injuries
after transplantation.39 These observations support the crucial
role of the SatC niche in muscle regeneration.
As mentioned, fast fibers are predominantly found in cleft
palate muscles compared with normal soft palate muscles.22–24
In general, the percentage of SatCs in fast muscle fibers is
significantly lower than in slow muscle fibers.41,42 This may
further decrease the SatC number in cleft palate muscles. In
addition, in vitro studies show that SatCs from fast muscle
fibers proliferate less than those from slow muscle fibers.39 In
rodent models for muscle atrophy induced by disuse, SatCs
decrease in number and display reduced function.43–45 Fur-
ther, impaired macrophage recruitment to the site of injury
and impaired macrophage function has been recently dem-
onstrated in this muscle atrophy model.46 A similar situation
may exist in cleft palate muscles that are limited to isometric
contractions and are therefore also atrophied. The accom-
panying poor capillary supply may further impair the re-
generation process and promote fibrosis.18,19
Disorganized muscle fibers are found at the attachment of
cleft palate muscles to the posterior border of the palatal
bone.16,17 This possibly prevents further postnatal myofiber
maturation by normal function.47
In summary, the lower regenerative capacity of bran-
chiomeric muscles in general, and the specific properties of
cleft palate muscles may compromise muscle regeneration
following surgical repair in cleft patients.
Soft Palate Muscles in Animal Models
Several mammalian species have been used for the study of
the normal and clefted palate. Themost frequently used animal
models are goats, mice, and rats.48–53 Up to now, tissue engi-
neering studies in the soft palate have not been performed.
Therefore, the selection of an appropriate animal model for the
study of the regeneration of the soft palate muscles is highly
important. The use of an existing congenital cleft palate model
in the goat51,54–56 is not feasible due to the high costs that limits
group size. Cleft palate models in knockout mice are generally
limited to embryological studies due to high mortality after
birth, and lack of reproducibility of the induced clefts.57–60
However, the widespread use of rodents for fundamental and
preclinical research ensures the availability of extensive tools
and markers. In addition, their low cost and ease of handling
make them themost suitablemodel for the development of soft
palate muscle engineering techniques.
Similar to humans, the soft palate muscles in rodents
possess a mixture of slow and fast fibers,61 and play an im-
portant role in swallowing and respiration.61,62 In addition,
the soft palate muscles in cleft animals also run parallel to the
margins of the cleft, and disorganized myofibers are pres-
ent.60 In contrast to humans,17 the development of the palatal
muscles in cleft palate mice is not delayed.63
The advantage of the rat over the mouse is its larger body
size favoring surgical manipulation of the soft palate. This
makes the rat the most suitable animal for experimental re-
search on muscle regeneration of the soft palate.
Tissue Engineering to Improve the Outcome
of Surgery
As mentioned in the previous sections, several biological
factors have been attributed to functional impairment of the
soft palate after surgical correction (Fig. 3): (1) Low intrinsic
regenerative capacity of soft palate muscles. As shown,
branchiomeric muscles including those of the soft palate,
have a low number of SatCs with a low rate of differentiation
compared with limb muscles, which may contribute to their
poor regenerative capacity. (2) Muscle properties related to
clefting. Clefted soft palate muscles contain a lower number
of myofibers and are highly disorganized close to the cleft
margin. This impedes the function of the reconstructed
muscle. (3) The development of fibrosis. The main harmful
effect of surgery is the development of muscle fibrosis, which
impairs the regeneration of muscle fibers. Strategies based on
tissue engineering may ameliorate the functional outcome of
surgical repair by approaching these three main issues.
Another factor that may influence the regeneration of
palatal muscles is age. In general, the number of SatCs in
growing postnatal muscle is about 30%–35% of all nuclei.64–66
In adulthood, only 1–4% of all nuclei belong to the SatC
population.67 Surgical repair of the soft palate generally
takes place in early childhood (6–36 months of age). After
birth, the soft palate muscles are still immature. A large
number of SatCs are present to fulfil the demands of
growth.68 In contrast, newborn SatCs seem to engraft less
efficiently than their adult counterparts.69 This should be
taken into account when developing tissue engineering
strategies for soft palate muscles.
Improving the intrinsic regenerative properties
of the soft palate muscles
Isolated SatCs may be used for cell-based therapy to im-
prove the regenerative capacity of the soft palatemuscles. It has
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been demonstrated that transplanted SatCs are able to form
newmyofibers and to self–renew.70 This approach has already
been used for the treatment of a variety of diseases such as
muscular dystrophy71 and myocardial infarction.72–74 Un-
fortunately, the success of transplantation of SatCs and myo-
blasts has only been limited. After isolation, SatCs seem to lose
their regenerative capacity in culture. In addition, their survival
and migration to the site of injury after injection is limited.75,76
Mesenchymal and embryonic stem cells can also differ-
entiate into skeletal muscle.77–79 However, only a small
fraction of cultured mesenchymal stem cells undergo fusion
into myofibers80 suggesting that these cells may not be an
appropriate cell type for therapeutic use.81 Embryonic stem
cells have a large potential for cell-based therapies for a wide
range of diseases.82,83 These cells may offer additional ad-
vantages such as their larger replicative potential, and the
possibility to perform gene targeting.84 However, embryonic
stem cell-derived myogenic populations with possible ther-
apeutic value have not been found up to now.
Alternatively, other nonmuscle stem cells such as me-
soangioblasts and pericytes also have myogenic poten-
tial.85,86 Both mesoangioblasts and pericytes can be delivered
systemically because of their ability to cross the endothelium.
This approach was successful for cell therapy in muscular
dystrophy.86,87 Nevertheless, the exact ability of nonmuscle
stem cells for muscle regeneration and their possible use in
cell therapy remain to be elucidated.88–91
As an alternative approach, the recruitment, proliferation,
and differentiation of SatCs already present in the soft palate
muscle may be stimulated by specific growth factors. As
mentioned, muscle growth and regeneration is controlled by
locally-produced growth factors, which stimulate SatCs such
as insulin-like growth factor 1 (IGF-1) and fibroblast growth
factor 2 (FGF-2). IGF-1 favors muscle regeneration by in-
creasing the rate of SatC proliferation and the formation of
myotubes.92–96 Similarly, FGF-2 stimulates muscle regener-
ation in vitro and in vivo by promoting the proliferation of
myoblasts after injury.97–100 Moreover, it facilitates the re-
cruitment and proliferation of SatCs101 and promotes an-
giogenesis.102,103 However, when growth factors are injected
in vivo, they rapidly lose their biological activity due to dif-
fusion and/or enzymatic inactivation.104 Because of this,
growth factors and attachment motifs have been incorpo-
rated into biodegradable scaffolds for controlled release.105
With microspheres prepared from materials such as poly-
lactic-co-glycolic acid, the release of such factors can be
controlled.106–108 In addition, fibrin and gelatin hydrogels
can give a sustained release of (growth) factors.109–112 These
new techniques may improve the delivery of factors to the
site of injury and stimulate muscle regeneration.
Although cell-based therapy seems to be promising for the
treatment of genetic muscle defects, it is probably not a
feasible option for cleft palate because it is a completely
different type of condition. For example, in degenerative
diseases like Duchenne muscular dystrophy, multiple cycles
of muscle degeneration and regeneration deplete the SatC
population.113 In contrast, in cleft palate, muscle SatCs are
preserved. In summary, growth factors and cytokines in a
suitable delivery system may stimulate proliferation and
differentiation of resident SatCs in the soft palate muscles
after surgical repair.
Correcting cleft-associated muscle abnormalities
Muscle is a highly organized structure consisting of long,
parallel multinucleated myotubes to generate sufficient force
for contraction.114 Therefore, the random myofiber orienta-
tion in cleft palate muscles impedes normal function after
surgical repair. The reduced function limits the switch from a
fast to a slow myofiber type.12,24 This may explain the in-
creased muscle fatigability observed in patients with velo-
pharyngeal dysfunction.23
Proper alignment of regenerating myotubes may be
achieved with scaffolds of specific design and surface to-
pography.115 Myoblasts are known to respond to the sur-
rounding topography,116 which leads to directional cell
FIG. 3. Muscle problems related to clefting.
Before surgery: (1) Low intrinsic regenerative
capacity: less number of satellite cells with a
low rate of differentiation, (2) Muscle
properties related to clefting: clefted soft
palate muscles contain lesser number of
myofibers and are highly disorganized. After
surgery: (3) Fibrosis. Adjuvant strategies
based on tissue engineering using (stem)
cells, growth factors, and scaffolds may
improve the outcome after surgery.
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growth.115 Hence, different techniques have been described
to control cellular alignment on micro- and nanostructured
surfaces produced either by chemical or topographic pat-
terning. These include electrospinning,117 photolithogra-
phy,118 and electron beam lithography.119
Aligned nanofiber meshes can be fabricated from biocom-
patible polymers such as poly-lactide or poly-glycolide-
co lactide via electrospinning.119 Muscle cells cultured in these
meshes show alignment and migration and a contractile phe-
notype.120,121 However, up to now the possibilities to control
the mechanical properties of these polymer meshes is limit-
ed.120 In addition, slowly degrading polymers persist in the
regenerated tissue for a long time. Since the repair of the soft
palate is generally performed in children, later growth of the
soft palate must be accommodated. Therefore, the use of rap-
idly degrading polymers seems to bemore suitable. Recently, it
was reported that growth factors can be printed onto sub-mi-
cron polystyrene fibers.122,123 A combination of a suitable
scaffold with growth factors and cytokines (e.g., stromal cell-
derived factor–1a) might favor migration,124 differentiation of
resident SatCs, and induce myofiber alignment.
Particularly in patients with wider clefts, the amount of
soft palate tissue is limited, which causes tension at the
junction of the hard and soft palate after surgical repair. It
has been proposed that scarring affects the length of the soft
palate in anteroposterior direction,125 which depends on the
specific technique used for closure.126 Alternatively, scarring
may contribute to a narrowing of the residual cleft after two-
stage palatoplasty.126–128 The site most likely to fistulize is at
the junction of the hard and soft palate.129 Fistulae usually
have been associated with the type of cleft, technique and
timing of repair, and the experience of the surgeon.130 Sub-
stitutes as decellularized dermal allograft have been suc-
cessfully used to close wide defects while preventing fistulae
formation.131 The use of scaffolds in the soft palate muscles
allows a defined architecture to guide cell growth and
development.
Preventing secondary effects of surgery: fibrosis
The deposition of excess ECM during regeneration may
lead to fibrosis and impaired muscle function. A key factor in
fibrosis is transforming growth factor-beta 1 (TGF-b1).132,133
It stimulates the synthesis of collagen and other extracellular
matrix components and promotes myofibroblast forma-
tion.134 Myostatin, another member of the TGF-b family,
inhibits muscle regeneration by the inhibition of SatC and
myoblast proliferation.135–138 In this way, TGF-b1 and
myostatin synergistically amplify the fibrotic process after
injury. In contrast, myostatin knockout mice develop less
fibrosis and display improved skeletal muscle regeneration
compared with wild-type mice.139
The inhibition of TGF-b1 and myostatin may prevent fi-
brous scar formation and improve muscle healing after in-
jury.139 Decorin is a member of the small leucine-rich
proteoglycan family, and it reduces both TGF-b1 and
myostatin activity.139–142 It thereby enhances the prolifera-
tion and differentiation of myogenic cells,143 and prevents
fibrosis.144 In addition, decorin upregulates the expression of
a variety of myogenic markers including Myf5, Myf6, MyoD,
and myogenin in vitro.145 Hepatocyte growth factor increases
decorin production by fibroblasts.146 Furthermore, small
signaling molecules such as nitric oxide down regulate TGF-
b1 activity.147 However, the importance of nitric oxide in
muscle regeneration must be further elucidated. In sum-
mary, the use of decorin and other factors that inhibit TGF-b1
and myostatin may prevent scar formation after surgical
correction of the soft cleft palate. A disadvantage might be
that anti-fibrotic therapy can diminish narrowing of the re-
sidual cleft after two-stage palatoplasty. Therefore, the long-
term effects of novel therapies based on tissue engineering in
such a complex anatomical environment is hard to predict.
Further research should elucidate the final outcome of these
new therapeutic approaches.
Conclusions
This review discusses the development and characteristics
of the soft palate muscles in the noncleft and cleft palate and
the process of muscle regeneration. Finally, tissue engineering
strategies are proposed to improve muscle regeneration after
the closure of the soft palate. The regeneration of muscles in
the soft palate after surgery is hampered because of (1) their
low intrinsic regenerative capacity, (2) muscle properties re-
lated to clefting, and (3) the development of fibrosis. We
propose the following strategies based on tissue engineering,
to improve the functional outcome after surgical repair.
To improve muscle regeneration (problem 1), growth
factors and cytokines might be applied to the surgical
wounds by incorporation into scaffolds or microspheres. The
growth factors should enhance SatC recruitment from the
adjacent muscle tissue and their proliferation and differen-
tiation into new myofibers. This will enhance the intrinsic
regeneration capacity of the soft palate muscles, and thereby
increase the functional outcome of surgery in terms of
number and maturation of myofibers.
Suitable scaffolds may also support the alignment of
myofibers and compensate the limited amount of tissue in
clefted muscles (problem 2). These scaffolds should offer an
architecture that guides cell growth and myofiber formation.
In terms of function, this approach will increase muscle
volume and force generation by the soft palate muscles.
To prevent fibrosis (problem 3), TGF-b1 and myostatin
activity can be inhibited by factors such as decorin. This will
reduce the formation of fibrotic tissue and stimulate prolif-
eration of myoblasts. The function of the soft palate muscles
after repair will thus improve by allowing myofiber forma-
tion and alignment (approaches 1 and 2).
Wrapping up, scaffolds that give a controlled release of
growth factors, guide the alignment of new myofibers, and
prevent fibrosis might improve muscle regeneration after
surgical repair of the cleft soft palate. Nevertheless, further
research is required in order to develop these functionalized
scaffolds.
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